Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831713 · ClinicalTrials.gov registry record
Pulmonary Blood Flow Measurements in CHF Patients
A clinical trial, sponsored by Echosense.
- Terminated
- Registry status
- 200
- Enrollment target
NCT01831713: Clinical Trial study, sponsored by Echosense.
NCT01831713 is a clinical trial that was terminated before completion, run by Echosense. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01831713 was terminated before completion, sponsored by Echosense.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Historically, transthoracic Doppler echocardiography has been unable to provide interpretable data of blood flow within the lung parenchyma because of air attenuation of Doppler signals. Recently, a transthoracic Doppler system known as the Sonara/tek Transcranial Doppler (TCD) System has been developed that can identify parenchymal pulmonary blood flow (PPBF) signals. The ability to non-invasively collect information regarding the pulmonary aspect of the cardio-pulmonary system may provide valuable information and new insights into the structural and functional characteristics of the lung parenchyma and vasculature in health and disease states.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-04 |
Why NCT01831713 stopped before completion
NCT01831713 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01831713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01831713 about?
NCT01831713 is a clinical study titled "Pulmonary Blood Flow Measurements in CHF Patients". Historically, transthoracic Doppler echocardiography has been unable to provide interpretable data of blood flow within the lung parenchyma because of air attenuation of Doppler signals. Recently, a transthoracic Doppler system known as the Sonara/tek Transcranial Doppler (TCD) System has been devel...
What is the current status of trial NCT01831713?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2012-09. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01831713?
This trial is sponsored by Echosense, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia